Quote (Thor123422 @ May 6 2021 12:06pm)
The biggest impediment to clinical trials in general is recruiting at each stage. That was not a problem and so the process was expedited without losing quality.
6 months and 45k people is actually more rigorous testing than is required for vaccines, and the results were so significant they could have gotten away with a tiny fraction of that to show efficacy.
https://wp.technologyreview.com/wp-content/uploads/2020/12/PFIZER_CHART_NEW.pngThis is the graph that demonstrates its efficacy. The rate of infection dropped by 95% in the vaccine group. This is consistent with what we know about effective vaccines since we've seen it with a dozen diseases so far. Mumps, measles, rubella, polio, smallpox, etc.
You don't seem to understand.
coronavirus like flu virus mutates a lot over time.
they made vaccines based on 1 protein, while a virus countains thousand of different ones, and they mutate over time which lower even more chance to be protected against new variants.
You can see how bad that method works to eliminate a virus if you take the data on flu virus. it simply doesn't work.
now what you are saying is that the vaccine is ready for public when in reality we are just in phase 3 of that experiment.
I don't know any other vaccine in the history of vaccination (at least for those who worked lol) that was released world wide only a few months after the first trial. it generally takes between 5 and 10+ years.
There is no science behind that rush but more like an collectiv hysterical fear.
I can't wait to see countries such as Israel re-opening their frontlines, then we will see how effective your vaccines are lmao